ARCT
Arcturus Therapeutics Holdings Inc
NASDAQ: ARCT · HEALTHCARE · BIOTECHNOLOGY
$8.40
-5.30% today
Updated 2026-04-29
Market cap
$238.75M
P/E ratio
—
P/S ratio
2.91x
EPS (TTM)
$-2.40
Dividend yield
—
52W range
$6 – $24
Volume
0.5M
Arcturus Therapeutics Holdings Inc (ARCT) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $0.00 | $0.00 | $6.14M | $20.38M | $13.00M | $15.75M | $20.79M | $9.54M | $12.36M | $205.75M | $157.75M | $138.39M | $67.22M |
| Revenue growth (YoY) | — | — | — | — | — | +232.1% | -36.2% | +21.2% | +32.0% | -54.1% | +29.6% | +1564.8% | -23.3% | -12.3% | -51.4% |
| Cost of revenue | — | — | $0.00 | $0.00 | $51000.00 | $294000.00 | $410000.00 | $16.98M | $32.44M | $55.95M | $173.76M | $143.05M | $2.96M | $3.54M | $3.02M |
| Gross profit | — | — | $0.00 | $0.00 | $6.09M | $20.09M | $12.59M | $-1.23M | $20.79M | $-46.41M | $12.36M | $205.75M | $157.75M | $138.39M | $64.20M |
| Gross margin | — | — | — | — | 99.2% | 98.6% | 96.8% | -7.8% | 100.0% | -486.5% | 100.0% | 100.0% | 100.0% | 100.0% | 95.5% |
| R&D | $1.82M | $818000.00 | $7.07M | $25.11M | $13.46M | $18.39M | $15.92M | $16.98M | $33.64M | $57.85M | $173.76M | $147.75M | $192.13M | $195.16M | $112.21M |
| SG&A | $2.08M | $683000.00 | $3.22M | $5.84M | $4.99M | $5.36M | $7.57M | $20.58M | $12.66M | $23.22M | $41.45M | $46.07M | $52.87M | $52.82M | $46.08M |
| Operating income | $-3.91M | $-1.50M | $-10.29M | $-33.08M | $-19.70M | $-25.17M | $-10.49M | $-21.81M | $-25.51M | $-71.52M | $-202.85M | $12.18M | $-78.20M | $-95.67M | $-74.95M |
| Operating margin | — | — | — | — | -320.9% | -123.5% | -80.7% | -138.5% | -122.7% | -749.8% | -1641.3% | 5.9% | -49.6% | -69.1% | -111.5% |
| EBITDA | $-3.92M | $-1.51M | $-10.28M | $-32.81M | $-1.72M | $-947000.00 | $-10.34M | $-20.71M | $-24.45M | $-70.64M | $-201.66M | $13.70M | $-24.16M | $-77.40M | $-71.93M |
| EBITDA margin | — | — | — | — | -28.0% | -4.6% | -79.6% | -131.5% | -117.6% | -740.6% | -1631.7% | 6.7% | -15.3% | -55.9% | -107.0% |
| EBIT | $-3.93M | $-1.51M | $-10.28M | $-32.84M | $-1.77M | $-1.24M | $-10.75M | $-21.30M | $-25.14M | $-71.52M | $-202.85M | $12.18M | $-27.12M | $-80.94M | $-74.95M |
| Interest expense | $44000.00 | $80000.00 | $197000.00 | $2000.00 | $251000.00 | $295000.00 | $150000.00 | $186000.00 | $854000.00 | $831000.00 | $2.67M | $3.00M | $767000.00 | $0.00 | $9000.00 |
| Income tax | $21000.00 | $65000.00 | $61000.00 | $-17000.00 | $51000.00 | $73000.00 | $1000.00 | $212000.00 | $-270000.00 | $-784000.00 | $3.19M | $1.29M | $1.83M | $-4000.00 | — |
| Effective tax rate | -0.5% | -4.3% | -0.6% | 0.1% | -0.3% | -0.3% | -0.0% | -1.0% | 1.0% | 1.1% | -1.6% | 12.2% | -6.6% | 0.0% | 0.0% |
| Net income | $-3.93M | $-1.58M | $-10.55M | $-32.83M | $-19.45M | $-24.60M | $-10.90M | $-21.79M | $-25.99M | $-72.15M | $-203.67M | $9.35M | $-29.73M | $-80.94M | $-65.78M |
| Net income growth (YoY) | — | +59.8% | -568.0% | -211.3% | +40.8% | -26.5% | +55.7% | -99.8% | -19.3% | -177.6% | -182.3% | +104.6% | -417.9% | -172.3% | +18.7% |
| Profit margin | — | — | — | — | -316.9% | -120.7% | -83.9% | -138.3% | -125.0% | -756.3% | -1648.0% | 4.5% | -18.8% | -58.5% | -97.9% |